(NASDAQ: SNSE) Sensei Biotherapeutics's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 5.19%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 14.9%.
Sensei Biotherapeutics's earnings in 2025 is -$26,823,000.On average, 2 Wall Street analysts forecast SNSE's earnings for 2025 to be -$23,693,333, with the lowest SNSE earnings forecast at -$24,469,026, and the highest SNSE earnings forecast at -$22,917,639. On average, 2 Wall Street analysts forecast SNSE's earnings for 2026 to be -$18,824,753, with the lowest SNSE earnings forecast at -$18,982,415, and the highest SNSE earnings forecast at -$18,667,092.
In 2027, SNSE is forecast to generate -$15,677,835 in earnings, with the lowest earnings forecast at -$15,677,835 and the highest earnings forecast at -$15,677,835.